stop your insults. (straw man argument? You revert to insults when your arguments are weak.)
What was your point?
The risks in terms of revenue are colossal, just for the Product in Japan. See antibody's posts on this.
BTW I don't claim to be expert in all aspects of MSB, and I don't think I have to post relentlessly on each point in detail. I simply am pointing out the flaws in your arguments which are major.
It would be a full time job comprehensively countering disinformation in here. I'm doing this in my spare time.
BTW I've said MSB is an emerging bluechip, and CSL is where we're heading IMO. I'm not going dignify your response any further with what you've overlooked.
People can read.
stop your insults. (straw man argument? You revert to insults...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.010(0.66%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.54 | $1.48 | $5.605M | 3.713M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 55197 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.53 | 29782 | 3 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |